Finance Trainee

Why Haleon's ₹2000 cr plant matters for Indian doctors. Specifically, consumer healthcare giant Haleon has announced plans to establish its first greenfield Haleon manufacturing facility in India. Consequently, this ₹2,000 crore investment in Pithampur, Madhya Pradesh, marks a massive shift in India's OTC market. Indeed, the plant will produce highly trusted oral health and wellness brands like Sensodyne, Crocin, and Eno. Therefore, medical and dental professionals across the country should note this key industry transformation. Why the new Haleon manufacturing facility matters for Indian doctors. Currently, Haleon relies heavily on third-party contract manufacturers for its Indian portfolio. However, this new greenfield plant will transition the company toward self-owned, fully automated production. Because of this shift, doctors can expect much tighter control over product quality and formulation consistency. Indeed, direct oversight of manufacturing ensures that Haleon consistently meets strict global quality standards. As a result, clinical safety and efficacy for patients will likely improve. Additionally, dentists can recommend Sensodyne with even greater clinical confidence, backed by advancements in dental clinical practice. Enhancing product availability and supply chain resilience. Importantly, Haleon aims to reach an additional 300 million consumers in India by 2030. To achieve this goal, local manufacturing is essential to prevent supply disruptions and sudden shortages. Moreover, the facility will serve as a hub for exporting products to other Asian markets. Thus, India is becoming a central player in the global consumer healthcare supply chain. Furthermore, this local setup aligns perfectly with the national 'Make in India' initiative. Ultimately, patients will benefit from more affordable and readily available everyday health products, which is a vital aspect of general practice and primary care delivery. Frequently asked questions. Q1: What is the focus of the new Haleon manufacturing facility in India? Specifically, the greenfield facility in Pithampur, Madhya Pradesh, will focus on producing oral care products like Sensodyne. Q2: When will the new facility become operational? Currently, the company expects the state-of-the-art automated plant to be fully functional by 2029-30. Q3: How does this investment benefit local healthcare distribution? Indeed, direct local manufacturing will enhance supply chain resilience and ensure consistent product availability for Indian patients. References * Haleon to set up ₹2000 cr manufacturing facility in MP - ETHealthworld * Haleon Expands India Footprint with New Greenfield Manufacturing Plant * Sensodyne maker Haleon to invest £175 million in first manufacturing plant in India - Mint Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.

Haleon chooses SAP solutions to replace legacy. Published: 03/25/2026 Meet the authors. * chris vavra wellesley information services. Key takeaways. * Haleon is transitioning to SAP Business Suite for its ERP needs, showcasing a pivotal shift towards AI-enabled enterprise ecosystems that drive commercial growth in the consumer health sector. * This migration from legacy systems to cloud ERP is essential for operational teams, as it connects fragmented workflows across finance, supply chain, HR and sales, improving real-time data accessibility and decision-making. * SAP Business Data Cloud is now central to Haleon's strategy, emphasizing the need for a harmonized data foundation to empower AI applications, thus impacting organizations' data management practices and transformation investment approaches. Haleon, the global consumer health company behind brands including Sensodyne, Advil and Panadol, has chosen SAP Business Suite to replace its legacy SAP ERP Central Component environment and build what both companies are calling an AI-ready enterprise foundation. The deal is a prominent ECC-to-cloud migration in the consumer health sector and sets a template for how large multinationals can tie digital transformation directly to commercial growth targets. Impact for technology leaders. The Haleon decision illustrates a shift in how cloud ERP projects are being scoped and sold. Rather than framing migration as a technology refresh, Haleon and SAP are explicitly connecting the SAP Business Suite investment to the company's "Win as One" commercial growth strategy, giving technology leaders a clearer line of business justification to bring to the board. Day to day, the transition from ECC to SAP Cloud ERP means finance, supply chain, HR and sales teams that currently navigate fragmented workflows will converge on one connected system with real-time data. SAP's Peter Maier framed it plainly: "AI outcomes depend on connected processes and trusted data." For operations leaders, that means fewer manual handoffs across planning and procurement cycles, faster exception resolution when supply signals shift, and dashboards that reflect the same version of the truth regardless of market or function. Explore related questions. Haleon is also deploying SAP Business Data Cloud to harmonize SAP and third-party data in a single governed source of truth - a pattern SAP calls central to enabling agentic AI, where software agents can identify issues and recommend actions without waiting for human-driven queries. As SAP CEO Christian Klein has described it, AI has to operate in the system of record where work actually happens so that outcomes are auditable and secure. For teams still on ECC, the message is direct: the path to production AI runs through a clean, cloud-native data foundation. How to evaluate and execute a move like Haleon's. For SAP customers benchmarking against Haleon's approach, several evaluation criteria stand out. Depth of AI readiness matters more than feature parity alone; organizations should assess whether a proposed cloud ERP target will support embedded Joule agents, multi-agent orchestration and no-copy data sharing with existing analytics platforms before committing to a migration path. SAP's Business Data Cloud now supports zero-copy connectivity with Databricks and has BigQuery support planned for the first half of 2026, widening the ecosystem in which harmonized SAP data can power AI use cases. The most common challenge in ECC migrations of this scale is preserving institutional process knowledge while eliminating customizations that block continuous updates. Best practices include a fit-to-standard assessment early in the program, phased cutover by region or function rather than a single global go-live, and leveraging SAP's clean-core extension model on SAP Business Technology Platform to handle edge-case requirements without modifying the core. Haleon's phased approach, with the ECC transition beginning later in 2026, reflects this discipline and gives its newly appointed Chief Transformation Officer time to align process redesign, operating model changes and technology delivery in parallel. What this means for sapinsiders. AI readiness now drives ERP migration business cases. Haleon's decision signals that organizations moving from ECC to SAP Cloud ERP are no longer justifying migration on cost or support timelines alone. They are anchoring it to agentic AI and Business Data Cloud capabilities, setting a new standard for how GSIs and enterprise architects should frame transformation investments. SAP Business Data Cloud becomes a strategic differentiator. By deploying Business Data Cloud alongside Cloud ERP to create a governed single source of truth for SAP and third-party data, Haleon reinforces that data harmonization is a prerequisite for production AI. This pushes SAP vendors and partners to treat BDC as a core platform component rather than an optional add-on. Clean-core discipline will define program success at scale. As global consumer companies like Haleon restructure operating models while simultaneously migrating ERP, transformation leaders must enforce fit-to-standard design and BTP-based extensions from the start, creating pressure on GSIs to build delivery methodologies that protect core integrity across multi-market, multi-wave rollouts.

Haleon chooses SAP solutions to accelerate growth through technology. March 25, 2026 WALLDORF - SAP SE (NYSE: SAP) and Haleon, a global consumer health company, today announced Haleon's decision to adopt SAP Business Suite to enhance the enterprise's digital infrastructure and advance AI capabilities across its business. SAP Business Suite: Deliver exceptional business value and help your business stay ready for what's next This decision will help Haleon operate, scale and serve consumers in new ways by building stronger, more agile foundations for delivering its trusted everyday health products. It marks a significant milestone in Haleon's transformation into a world-class consumer company. "Delivering a better consumer experience starts with strong foundations, and leading digital technology and infrastructure are at the heart of this," said Claire Dickson, Haleon's chief digital and technology officer. "Our latest partnership with SAP is another important step in our journey to becoming a world-class consumer company. It will revolutionize how we operate, with AI-enabled systems driving faster, simpler, more integrated ways of working. This will allow our people to focus on what matters most - serving consumers and unlocking growth." SAP Business Suite will drive the simplification and standardization of critical processes across Haleon's global operations, enabling more integrated, automated end-to-end processes across diverse parts of the organization. With clearer visibility across markets and more intuitive systems replacing fragmented workflows, the business can operate with greater speed, consistency and resilience. These improvements strengthen supply chain responsiveness, support innovation and help Haleon better respond to changing consumer needs. This enables Haleon to deliver trusted everyday health products at scale while strengthening collaboration with the healthcare professionals who recommend its products to consumers worldwide. Haleon can drive greater business efficiencies by integrating core processes across finance, supply chain, HR and sales in one connected system with real-time data. By building AI into everyday work and embedding it within Haleon's digital infrastructure and across its functions, teams can make better data-driven decisions and respond more quickly to changing consumer needs. The automation of routine work across multiple functions frees up employees' time so they can focus on more strategic work that delivers value for the business and consumers while accelerating growth. This digital transformation program builds on a long-standing relationship between the two companies, with the transition from Haleon's current platform on SAP ERP Central Component beginning later this year. "AI outcomes depend on connected processes and trusted data," said Peter Maier, SAP's senior vice president for strategic customer engagements. "With SAP Business Suite, Haleon is building an AI-ready foundation that embeds intelligence across the enterprise, helping simplify operations, improve resilience and scale innovation." Haleon plans to adopt SAP Cloud ERP applications with embedded AI and deploy the SAP Business Data Cloud solution to harmonize SAP software and third-party data in a governed, single source of truth. This connected platform will be able to support AI-assisted innovation and enable agentic AI, where AI agents can identify issues earlier and recommend actions across key business processes. Media Contacts: Lawrie Benfield, SAP, +44 7776515259, [email protected], GMT Sonya Domanski, SAP, +44 7345465928, [email protected], GMT SAP Press Room; [email protected] Gemma Thomas, Haleon, [email protected] The agreement referenced in this announcement was signed outside SAP's first quarter reporting period. Top image courtesy of Haleon This document contains forward-looking statements, which are predictions, projections, or other statements about future events. These statements are based on current expectations, forecasts, and assumptions that are subject to risks and uncertainties that could cause actual results and outcomes to materially differ. Additional information regarding these risks and uncertainties may be found in its filings with the Securities and Exchange Commission, including but not limited to the risk factors section of SAP's 2025 Annual Report on Form 20-F. (C) 2026 SAP SE. All rights reserved. SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices.